Development Plan

2020

Preclinical Studies Completion

LignaMed expects to complete preclinical studies for LGM2605 as device in lung transplant in 2020

LignaMed plans to submit device package for lung transplant in 2020

2021

Submit IND Application to FDA

An IND submission for asthma is planned for 2021

2022

Clinical Studies

Initiation of clinical studies for asthma is planned for 2022

Completion of clinical studies for device is planned for 2022

2023

FDA Approval & Product Launch - device for lung transplant